[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Articles archive::
For Reviewers::
Contact us::
Basic and Clinical Biochemistry and Nutrition
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 24, Issue 1 (Bimonthly 2020) ::
Feyz 2020, 24(1): 48-55 Back to browse issues page
The effect of Quinacrine on MMP1 Gene Expression in MDA-MB 231 and MCF7 cell lines of breast cancer
Zahra Ganjkhanlou , Majid Sirati-Sabet , Siamak Salami , Reza Mirfakhraie
Department of Clinical Biochemistry, Faculty of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran. , sirati@sbmu.ac.ir
Abstract:   (2175 Views)
Background:  Breast cancer is the most frequent malignancy in women worldwide and occurs when cells in the breast begin to grow out of control. Matrix metalloproteinases (MMP), including MMP1 protein, are important in the progression of various types of cancer. Quinacrine, a derivative of 9-aminoacridine, has been shown to inhibit the growth of several types of cancer cells. In this study, we examined the effect of Quinacrine on MMP1 gene expression in breast cancer cell lines MDA-MB 231 and MCF7. MDA-MB 231 cell line has triple negative breast cancer cells properties.
Materials and Methods: Breast cancer cell lines, MDA-MB 231 and MCF7, were treated with 0.5 µM Quinacrine for 3 days. The dose was selected using MTT assay. Expression of MMP1 gene was quantified by Real-time PCR. Significance of observations were statistically checked by t-test using P<0.05 as the level of significance.
Results: Quinacrine did not have meaningful effect on MMP1 gene expression on MDA-MB 231 and MCF7 cell lines in 0.5 µM concentration for 72 hours.
Conclusion: MMP1 gene is important in metastasis and the present study showed that Quinacrine could not affect the expression of this gene on these breast cancer cell lines.
Keywords: Gene expression, MCF7, MDA-MB 231, MMP1, Quinacrine
Full-Text [PDF 309 kb]   (819 Downloads)    
Type of Study: Research | Subject: medicine, paraclinic
Received: 2018/09/10 | Revised: 2020/05/16 | Accepted: 2020/02/22 | Published: 2020/05/16
1. Azizi MH, Bahadori M, Azizi F. History of cancer in Iran. Arch Iran Med 2013; 16(10): 613-22.
2. Ban KA, Godellas CV. Epidemiology of breast cancer. Surg Oncol Clin N Am 2014; 23(3): 409-22.
3. Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, et al. Breast cancer. Nat Rev Dis Primers 2019; 5(1): 66-96.
4. Waks AG, Winer EP. Breast cancer treatment: a review. Jama 2019; 321(3): 288-300.
5. Cetin I, Topcul M. Triple negative breast cancer. Asian Pac J Cancer Prev 2014; 15(6): 2427-31.
6. Chavez KJ, Garimella SV, Lipkowitz S. Triple negative breast cancer cell lines: one tool in the search for better treatment of triple negative breast cancer. Breast Dis 2010; 32(1-2): 1-17.
7. Bozzuto G, Ruggieri P, Molinari A. Molecular aspects of tumor cell migration and invasion. Ann Ist Super Sanita 2010; 46: 66-80.
8. Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N. Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2000; 2(4): 252-8.
9. Pardo A, Selman M. MMP-1: the elder of the family. Int J Biochem Cell B 2005; 37(2):283-8.
10. Farooqui M, Bohrer LR, Brady NJ, Chuntova P, Kemp SE, Wardwell CT, et al. Epiregulin contributes to breast tumorigenesis through regulating matrix metalloproteinase 1 and promoting cell survival. Mol Cancer 2015; 14(1): 138-51.
11. Shen CJ, Kuo YL, Chen CC, Chen MJ, Cheng YM. MMP1 expression is activated by Slug and enhances multi-drug resistance (MDR) in breast cancer. PloS one 2017; 12(3): 1-13.
12. Liu H, Kato Y, Erzinger SA, Kiriakova GM, Qian Y, Palmieri D, et al. The role of MMP-1 in breast cancer growth and metastasis to the brain in a xenograft model. BMC cancer 2012; 12(1): 583-95.
13. Ehsanian R, Van Waes C, Feller SM. Beyond DNA binding-a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers. J Cell Commun Signal 2011; 9(13): 1-18.
14. Gurova KV, Hill JE, Guo C, Prokvolit A, Burdelya LG, Samoylova E, et al. Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-κB-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci 2005; 102(48): 17448-53.
15. Jani TS, DeVecchio J, Mazumdar T, Agyeman A, Houghton JA. Inhibition of NF-κB signaling by quinacrine is cytotoxic to human colon carcinoma cell lines and is synergistic in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) or oxaliplatin. J Biol Chem 2010; 285(25): 19162-72.
16. Wang Y, Bi Q, Dong L, Li X, Ge X, Zhang X, et al. Quinacrine enhances cisplatin-induced cytotoxicity in four cancer cell lines. Chemotherapy 2010; 56(2): 127-34.
17. Preet R, Mohapatra P, Mohanty S, Sahu SK, Choudhuri T, Wyatt MD, et al. Quinacrine has anticancer activity in breast cancer cells through inhibition of topoisomerase activity. Int J Cancer 2012; 130(7): 1660-70.
18. Pfaffl MW. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res 2001; 29(9): 1-6.
19. Angelucci C, Maulucci G, Colabianchi A, Iacopino F, D'Alessio A, Maiorana A, et al. Stearoyl-CoA desaturase 1 and paracrine diffusible signals have a major role in the promotion of breast cancer cell migration induced by cancer-associated fibroblasts. Br J Cancer 2015; 112(10): 1675-86.
20. Comşa Şe, Cimpean AM, Raica M. The story of MCF-7 breast cancer cell line: 40 years of experience in research. Anticancer Res 2015; 35(6): 3147-54.
21. Lee AV, Oesterreich S, Davidson NE. MCF-7 cells-Changing the course of breast cancer research and care for 45 years. J Natl Cancer Inst 2015; 107(7): 1-4.
22. Gallant J-N, Allen JE, Smith CD, Dicker DT, Wang W, Dolloff NG, et al. Quinacrine synergizes with 5-fluorouracil and other therapies in colorectal cancer. Cancer Biol Ther 2011; 12(3): 239-51.
23. Satapathy SR, Siddharth S, Das D, Nayak A, Kundu CN. Enhancement of cytotoxicity and inhibition of angiogenesis in oral cancer stem cells by a hybrid nanoparticle of bioactive quinacrine and silver: implication of base excision repair cascade. Mol Pharm 2015; 12(11): 4011-25.
24. Vandooren J, Van den Steen PE, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade. Crit Rev Biochem Mol 2013; 48(3): 222-72.
25. Fanjul-Fernández M, Folgueras AR, Cabrera S, López-Otín C. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. BBA - Mol Cell Res 2010; 1803(1): 3-19.
26. Cheng S, Tada M, Hida Y, Asano T, Kuramae T, Takemoto N, et al. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma. J Surg Res 2008; 146(1): 104-9.
27. Rattanasinchai C, Llewellyn B, Conrad SE, Gallo KA. Mixed-Lineage Kinase 3 signals through the FRA1-MMP1 axis to drive triple-negative breast cancer invasion and transendothelial migration. Cancer Res 2017; 77(13 Suppl): 2374-5.
28. Teronen O, Konttinen YT, Lindqvist C, Salo T, Ingman T, Lauhio A, et al. Inhibition of matrix metalloproteinase-1 by dichloromethylene bisphosphonate (clodronate). Calcified Tissue Int 1997; 61(1): 59-61.
29. Liu Q, Loo WTY, Sze SCW, Tong Y. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NF-κB, cyclinD and MMP-1 transcription. Phytomedicine 2009; 16(10): 916-22.
30. Subbarayan PR, Sarkar M, Impellizzeri S, Raymo F, Lokeshwar BL, Kumar P, et al. Anti-proliferative and anti-cancer properties of Achyranthes aspera: specific inhibitory activity against pancreatic cancer cells. J Ethnopharmacol 2010; 131(1): 78-82.
31. Noratto G, Porter W, Byrne D, Cisneros-Zevallos L. Polyphenolics from peach (Prunus persica var. Rich Lady) inhibit tumor growth and metastasis of MDA-MB-435 breast cancer cells in vivo. J Nutr Biochem 2014; 25(7): 796-800.
32. Kunte M, Desai K. The protein extract of chlorella minutissima inhibits the expression of MMP-1, MMP-2 and MMP-9 in cancer cells through upregulation of TIMP-3 and down regulation of c-Jun. Cell J (Yakhteh) 2018; 20(2): 211-9.
33. Ryu JY, Na EJ. MMP expression alteration and MMP-1 production control by syringic acid via AP-1 mechanism. Biomedical Dermatol 2018; 2(1): 15-24.
34. Zhao P, Alam M, Lee SH. Protection of UVB-induced photoaging by Fuzhuan-Brick tea aqueous extract via MAPKs/Nrf2-mediated down-regulation of MMP-1. Nutrients 2019; 11(1): 60-75.
35. Liu SC, Tsai C-H, Wu TY, Tsai CH, Tsai FJ, Chung JG, et al. Soya-cerebroside reduces IL-1β-induced MMP-1 production in chondrocytes and inhibits cartilage degradation: implications for the treatment of osteoarthritis. Food Agr Immunol 2019; 30(1): 620-32.
Send email to the article author

Add your comments about this article
Your username or Email:


XML   Persian Abstract   Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Ganjkhanlou Z, Sirati-Sabet M, Salami S, Mirfakhraie R. The effect of Quinacrine on MMP1 Gene Expression in MDA-MB 231 and MCF7 cell lines of breast cancer. Feyz 2020; 24 (1) :48-55
URL: http://feyz.kaums.ac.ir/article-1-3693-en.html

Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 24, Issue 1 (Bimonthly 2020) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4645